CAS 804518-63-6
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
10 Produkte gefunden.
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl
CAS:Formel:C24H33N5O4SReinheit:99%Farbe und Form:SolidMolekulargewicht:487.6149Ref: IN-DA00GAHY
5mgNachfragen10mgNachfragen250mgNachfragen25mg180,00€50mg222,00€1mg359,00€100mg526,00€2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
CAS:2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-oneFormel:C24H33N5O4SReinheit:98%Molekulargewicht:487.63Yonkenafil
CAS:Yonkenafil is a potent, selective inhibitor of the enzyme cGMP-specific phosphodiesterase type 5 (PDE5). It is used for the treatment of erectile dysfunction. Yonkenafil has been shown to inhibit nitric oxide synthase (NOS) activity, which may be responsible for its neuroprotective effect. This compound also inhibits microglia activation and neuronal death in vitro and in vivo. Yonkenafil has been shown to be effective in the treatment of Parkinson's disease symptoms, such as cognitive impairment and motor deficits.Formel:C24H33N5O4SReinheit:Min. 95%Molekulargewicht:487.6 g/molYonkenafil
CAS:Yonkenafil (Tunodafil) is a PDE5 inhibitor that improves neurological outcomes and cognitive function in models.Formel:C24H33N5O4SReinheit:99.99%Farbe und Form:Yellow SolidMolekulargewicht:487.61
